Scientific article
English

Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD-scid IL-2rgnull RIP-DTR mice engrafted with human islets

Published inDiabetes, metabolic syndrome and obesity, vol. 8, p. 387-398
Publication date2015
Citation (ISO format)
BORTELL, Rita et al. Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD-scid IL-2rgnull RIP-DTR mice engrafted with human islets. In: Diabetes, metabolic syndrome and obesity, 2015, vol. 8, p. 387–398. doi: 10.2147/DMSO.S87253
Main files (1)
Article (Submitted version)
accessLevelPublic
Identifiers
Journal ISSN1178-7007
631views
538downloads

Technical informations

Creation01/12/2015 17:00:00
First validation01/12/2015 17:00:00
Update time15/03/2023 01:09:03
Status update15/03/2023 01:09:02
Last indexation31/10/2024 03:47:10
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack